Skip to headlines
clockwire Search
LIVE
Foreign minister Lin calls for closer ties with Texas SPIL announces deal with Nvidia Watery victory Taiwan eyeing US-China-Russia talks CIB identifies 30 suspected election interference cases Xi welcomes Trump to China ahead of summit NASA’s Voyager 1 reaches one light-day milestone after 50 years in space More rational antibiotic use needed, hospital says Legalize cancer drug fund: groups Taipei indicts escape room owner over worker’s death Chiayi mayoral candidate sorry for public urination Researchers tag two butterflies with microtransmitters Complete works of Taiwanese Hakka writer Wu Zhuo-liu released Taichung candidates present policies Funding for Kang Ding-class frigate released
‹ Back to your news

MARKETS United States

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

Covered by 1 source First reported

How each outlet tells it

CNBC (US) · private

Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy

The telehealth company will now offer compounded forms of sermorelin, glutathione, NAD+, vitamin B-12 and L-carnitine, none of which are approved by the FDA.

Read at CNBC